Musings on the struggle--Part V: Beginning the N2/TIL protocol.
Anderson
W F
WF
D015415:Biomarkers; D002985:Clinical Protocols; D004351:Drug Resistance; D006077:Government Agencies / Q000331:legislation & jurisprudence; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000191:economics / Q000331:legislation & jurisprudence*; D019868:Kanamycin Kinase; D016246:Lymphocytes, Tumor-Infiltrating / Q000637:transplantation*; D008545:Melanoma / Q000473:pathology*; D009316:National Institutes of Health (U.S.); D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000235:genetics; D017410:Practice Guidelines as Topic; D011993:Recombinant Fusion Proteins; D012109:Research Support as Topic / Q000331:legislation & jurisprudence; D014162:Transfection; D014481:United States
D015415:Biomarkers; D011993:Recombinant Fusion Proteins; D017853:Phosphotransferases (Alcohol Group Acceptor); D019868:Kanamycin Kinase